The effect of spironolactone on morbidity and mortality in patients with severe heart failure (1999)
Source: The New England Journal of Medicine. Unidade: FMRP
Assunto: DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PITI, Bertram et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. The New England Journal of Medicine, v. 341, n. 10, p. 709-717, 1999Tradução . . Acesso em: 17 maio 2024.APA
Piti, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., et al. (1999). The effect of spironolactone on morbidity and mortality in patients with severe heart failure. The New England Journal of Medicine, 341( 10), 709-717.NLM
Piti B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. The New England Journal of Medicine. 1999 ; 341( 10): 709-717.[citado 2024 maio 17 ]Vancouver
Piti B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. The New England Journal of Medicine. 1999 ; 341( 10): 709-717.[citado 2024 maio 17 ]